Aimco Pesticides Fair Value
Aimco Pesticides fair value. Aimco Pesticides (AIMCOPEST) average fair value is ₹49.07 across 4 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF), vs a current market price of ₹40.79 (+20.3%), fair value range ₹13.06–₹89.26. Explore AIMCOPEST fundamental worth to estimate fundamental worth using multiple valuation models.
Fair Value Analysis Export
AIMCOPEST Fair Value vs Current Price — Valuation Summary
AIMCOPEST average fair value, fair value range, price gap and valuation status across 4 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Discounted Cash Flow (DCF). For live price and a broader fundamental view, visit Aimco Pesticides share price screener.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Discounted Cash Flow (DCF)
AIMCOPEST Fair Value Analysis — Data Sources & Coverage
Aimco Pesticides financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. Check Aimco Pesticides market cap to track the company's total market size over time.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
AIMCOPEST vs Chemicals Sector Peers — P/E, P/B & Market Cap
Aimco Pesticides P/E ratio, P/B ratio and market capitalisation vs Chemicals sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Mehul Colours | MEHUL | 10.51 | 1.33 | ₹55 |
| Chambal Fertilisers & Ch… | CHAMBLFERT | 8.5 | 1.58 | ₹15,998 |
| Epigral | EPIGRAL | 10.84 | 1.74 | ₹3,648 |
| PB Global | PBGLOBAL | -0.03 | 0.02 | ₹0 |
| Blue Pearl Agriventures | BPAGRI | 364.0 | 7.13 | ₹433 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.